Sweet stuff is dangerous in DLBCL
success will depend on the outcomes of future early-phase trials.However, the groundwork laid by this study is both scientifically sound and clinically hopeful.
Authors
- Leticia Quintanilla-Martı́nez (ORCID: https://orcid.org/0000-0001-7156-5365)
- Falko Fend (ORCID: https://orcid.org/0000-0002-5496-293X)
Institutions
- University Children's Hospital Tübingen (DE)
Publication Details
- Journal
- Blood
- Published
- 2025-12-04
- DOI
- https://doi.org/10.1182/blood.2025031082
- Primary Topic
- Cutaneous lymphoproliferative disorders research
- Type
- article
- Field-Weighted Citation Impact
- 0.00